Affiliation:
1. Division of Epidemiology
2. Laboratory of Clinical Microbiology, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv 64239, Israel
Abstract
ABSTRACT
We compared the susceptibility of 312 extended-spectrum β-lactamase (ESBL)-producing
Enterobacteriaceae
isolates with that of 1,216 ESBL nonproducers. Of ESBL producers, 25% were susceptible to gentamicin, 30% to trimethoprim-sulfamethoxazole, 41% to ciprofloxacin, and 60% to piperacillin-tazobactam. ESBL nonproducers were more often susceptible to these agents. ESBL-producing
Enterobacteriaceae
represent a major source of resistance to various antibiotics.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology